SEC 13F Intelligence

Norris Perne & French LLP/Mi / JNJ

Norris Perne & French LLP/Mi’s Johnson & Johnson Position

Does Norris Perne & French LLP/Mi own Johnson & Johnson (JNJ)? Yes — 61.3K shares worth $15M (+1.00% of its 13F portfolio) as of Q1 2026, down from 186.6K shares the prior filed quarter.

Position Value
$15M
Q1 2026
Shares
61.3K
% of Portfolio
+1.00%
Quarters Held
30
currently held

Position History JNJ

Reported value by quarter
Q4 ’18: $13MQ4 ’18Q1 ’19: $15MQ2 ’19: $15MQ3 ’19: $15MQ4 ’19: $18MQ4 ’19Q1 ’20: $19MQ2 ’20: $19MQ3 ’20: $21MQ4 ’20: $25MQ4 ’20Q1 ’21: $25MQ2 ’21: $25MQ3 ’21: $24MQ4 ’21: $24MQ4 ’21Q1 ’22: $24MQ2 ’22: $15MQ3 ’22: $14MQ4 ’22: $16MQ4 ’22Q1 ’23: $14MQ2 ’23: $16MQ3 ’23: $15MQ4 ’23: $16MQ4 ’23Q1 ’24: $17MQ2 ’24: $23MQ3 ’24: $30MQ4 ’24: $27MQ4 ’24Q1 ’25: $31MQ2 ’25: $29MQ3 ’25: $36MQ4 ’25: $39MQ4 ’25Q1 ’26: $15Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202661.3K$15M+1.00%
Q4 2025186.6K$39M+2.55%
Q3 2025191.9K$36M+2.46%
Q2 2025191.6K$29M+2.04%
Q1 2025187.4K$31M+2.34%
Q4 2024187.3K$27M+1.95%
Q3 2024187.2K$30M+2.08%
Q2 2024154.2K$23M+1.63%
Q1 2024107.3K$17M+1.22%
Q4 2023103.1K$16M+1.25%
Q3 202399.0K$15M+1.35%
Q2 202397.1K$16M+1.35%
Q1 202392.7K$14M+1.32%
Q4 202287.8K$16M+1.53%
Q3 202285.7K$14M+1.46%
Q2 202284.3K$15M+1.44%
Q1 2022136.7K$24M+1.96%
Q4 2021137.5K$24M+1.82%
Q3 2021150.8K$24M+2.09%
Q2 2021151.0K$25M+2.14%
Q1 2021149.2K$25M+2.27%
Q4 2020161.7K$25M+2.40%
Q3 2020140.5K$21M+2.27%
Q2 2020137.6K$19M+2.35%
Q1 2020143.1K$19M+2.82%
Q4 2019123.0K$18M+2.14%
Q3 2019114.0K$15M+1.84%
Q2 2019111.3K$15M+1.96%
Q1 2019109.9K$15M+2.02%
Q4 2018103.6K$13M+2.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Norris Perne & French LLP/Mi’s full portfolio or all institutional holders of JNJ.